Table 1.
Characteristics of the 239 ULMS SKS procedures
| Characteristic | N |
|---|---|
| Mean age | 68.0 (10) |
| Male gender | 168 (70%) |
| Urgency | |
| Routine | 116 (48.5%) |
| Urgent | 87 (36.4%) |
| Emergency | 37 (15.5%) |
| Comorbiditya | |
| Hypertension | 42 (17.5%) |
| Diabetes mellitus | 40 (16.7%) |
| Renal failure$ | 13 (5.4%) |
| Chronic lung disease | 20 (8.4%) |
| Anemia | 19 (7.9%) |
| Valvular heart disease | 30 (12.5%) |
| Left ventricular systolic impairmentb | 51 (21.3%) |
| Peripheral vascular disease | 23 (9.6) |
| Stroke | 10 (4.2%) |
| Obese | 32 (13.3%) |
| Procedural details | |
| Catastrophic state | 16 (6.7) |
| Intra‐aortic balloon counterpulsation use | 40 (16.7%) |
| Glycoprotein IIbIIIa use | 83 (34.7) |
| Inappropriate or turned down for surgery | 137 (57.3%) |
| Complete revascularization achieved | 171 (71.5%) |
| Stent details | |
| 1st generation DES | 55% (all Taxus) |
| 2nd generation DES | 45% of which |
| 78% Promus | |
| 11% Xience | |
| 6% Resolute | |
| 4% Endeavour | |
| 3% Ultimaster | |
| Mean stent size LMS‐LAD | 3.10 (0.4) × 23.1 (5.3) mm |
| Mean stent size LMS‐LCx | 3.16 (1.1) × 22.0 (5.5) mm |
a
Known diagnosis at time of procedure. $Creatinine >200 µmol/L.
b
bGraded as at least moderate. Data are presented as either mean (SD) or N (%).